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Animal cells swell rapidly in response to a drop in the
osmolarity of their surrounding fluid. To compensate for
this, the cell releases osmolytes and water follows, a
process known as regulatory volume decrease. One ubiqui-
tous and much-studied pathway for osmolyte release
involves the ‘volume sensitive osmolyte and anion
channel’ (VSOAC) [1]. An early single-channel study of the
VSOAC showed that it is outwardly rectifying, has a con-
ductance of ~50 pS in 150 mM Cl– and, most importantly,
is either almost always open or completely closed. These
observations suggested that “graded increases in cell mem-
brane Cl– permeability [in response to cell swelling] are
effected by an increase in the number of active channels
rather than a graded increase in the open probability” [2].
Although neither the molecular nature of the VSOAC nor
its mechanism of action have been established, consider-
able evidence has been marshaled to indicate that the
channel may be wholly or partly composed of ICln [1], as
first proposed by Paulmichl et al. [3]. ICln is a 235-residue
protein that is endogenously expressed in most cells, but
that gives rise to increased VSOAC currents when its level
is increased by exogenous expression in transfected cells.
Modeling suggests that a dimer of ICln may form an eight-
stranded antiparallel b barrel that, like a porin molecule,
spans the membrane to form a pore [3]. VSOAC’s unusual
channel kinetics have been attributed to the release of
ICln from internal binding sites and insertion into the
plasma membrane [1]. An alternative suggestion that has
attracted a lot of attention is that the VSOAC is made up
of P-glycoprotein. Recent results rule out this possibility,
though P-glycoprotein expression does seem to influence
swelling-activated conductances.
Is P-glycoprotein also VSOAC?
P-glycoprotein is a member of a large class of transmem-
brane transport proteins, the ATP-binding cassette (ABC)
transporters, which have two distinctive nucleotide-binding
domains [4]. P-glycoprotein is also known as a multidrug-
resistance (mdr) protein — its expression makes cancer
cells simultaneously resistant to a wide variety of
chemotherapeutic drugs [5]. It has been suggested that P-
glycoprotein has this effect because it exports chemother-
apeutic agents out of the cells in which it is expressed. In
normal mice, this promiscuous transport activity may be
put to good use keeping toxins away from the brain — P-
glycoprotein is abundant in cells of the blood–brain
barrier, and ‘knockout’ mice lacking P-glycoprotein,
although otherwise healthy, are highly susceptible to
certain toxins which accumulate to abnormally high levels
in their brains [6].
The odyssey linking VSOAC and P-glycoprotein began
with a comparison of domain and sequence similarities
between P-glycoprotein and the cystic fibrosis transmem-
brane conductance regulator (CFTR). Because the primary
physiological defect in cystic fibrosis is a loss of a specific
type of epithelial Cl– conductance [7], it was suspected that
the affected gene would code for a Cl– channel. When the
sequence of CFTR revealed its resemblance to ABC trans-
porters, however, speculation began that CFTR somehow
used its transport properties to function as a conductance
regulator, an idea that persists to this day. When the evi-
dence that CFTR is an intrinsic Cl– channel became
unequivocal [8,9], it was suggested that P-glycoprotein
might also be a Cl– channel, and that both molecules might
have dual roles as ion channels and efflux pumps [10].
The possibility of P-glycoprotein having a channel func-
tion was tested by comparing whole-cell Cl– currents in
cells that did or did not express P-glycoprotein. It was
reported that swelling-activated Cl– currents occur only
when P-glycoprotein is expressed, and it was concluded
that P-glycoprotein is a swelling-activated Cl– channel —
the same channel we would now designate as VSOAC [10].
This was followed by a much more detailed study, from
which it was concluded that P-glycoprotein functioned
alternately as either a Cl– channel or an efflux pump, with
the two functional states being mutually exclusive [11]. 
These reports generated a great deal of excitement [12],
but were also greeted with considerable skepticism,
because almost everyone who carries out whole-cell
studies with permeant anions present quickly discovers
that large, VSOAC-mediated currents are ubiquitous
unless pipette and bath solutions are carefully balanced to
avoid cell swelling [13]. Expression of P-glycoprotein is
not ubiquitous, however, and more than ten papers
[14–24] have since reported the lack of a correlation
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between P-glycoprotein expression and the presence of
VSOAC currents. These studies used many different cell
types and a wide variety of methods for manipulating P-
glycoprotein and for assessing channel activity. All of them
concluded that P-glycoprotein is not the VSOAC channel.
It is now clear that the original interpretation was wrong: P-
glycoprotein is not VSOAC.
Can the disparate results be reconciled?
In an attempt to explain both the original observations and
these many failures to repeat them, we carried out a simple
experiment in which the osmotic challenge to the cell was
varied, while VSOAC activity was monitored either by
whole-cell recordings or 125I efflux [25]. This showed that
cells without P-glycoprotein had large VSOAC-mediated
currents, but that cells expressing P-glycoprotein were
more sensitive to osmotic challenge. By carefully titrating
the degree of osmotic challenge, it was possible to achieve
an absolute difference between the two types of cell, as
was noted in the original studies [10,11], whereas at larger
dilutions the two types of cell appear equivalent.
This method has now been extended to show that expres-
sion of a mouse P-glycoprotein isoform (P-gp1a) influences
only the rate of VSOAC activation, with steady-state con-
ductance values being equivalent in whole-cell recordings
[26]. Three other findings of interest have emerged from
this study. Firstly, cells expressing mouse P-gp1a showed a
more rapid volume recovery after swelling. Secondly, in the
cell line used, the resting K+ conductance was high, and not
further increased by cell swelling, so it was not possible to
determine if P-glycoprotein expression had any influence
on the swelling-induced K+-conductance increase observed
previously [25,27]. And thirdly, expression of mouse P-
gp1b, which is 84 % similar to mouse P-gp1a and which also
confers multidrug resistance, did not influence the
swelling-activated responses [26]. These findings support
the authors’ earlier assertions that the effects observed are
specific to P-glycoprotein, and that they can have conse-
quences for volume recovery. They also confirm the con-
sensus finding that P-glycoprotein cannot be VSOAC.
Is P-glycoprotein a channel regulator?
How should we interpret the influence that P-glycopro-
tein expression has on VSOAC currents in some cells?
One interpretation is that P-glycoprotein is a specific
channel regulator that facilitates the rate of VSOAC acti-
vation [26]. In view of the evidence that CFTR and the
sulfonylurea receptor also regulate ion channels, it has
been suggested that a common regulatory mechanism
might underlie all such actions [26].
A different view is that the concept of ‘channel regulator’
has been stretched too far, and is now used indiscrimi-
nately to describe any influence, no matter how remote, of
an expressed protein on a conductance. Almost nothing is
known about the steps that intervene between a hypoos-
motic challenge and activation of VSOAC, but the long
latency of the response indicates that the pathway might
be complex. P-glycoprotein might influence any step in
the pathway, and the resulting effect on VSOAC activity
might be incidental. 
A concrete example can best illustrate how the term
‘channel regulator’ can obscure understanding. When the
protein Chip28 (aquaporin) was expressed at high levels in
oocytes, it allowed more rapid swelling in the face of
osmotic challenge. If this expression study had been
carried out while measuring VSOAC currents, it might
have been concluded that Chip28 is a Cl– channel or a
channel regulator. Fortunately, it was correctly determined
that Chip28 forms water channels [28]. Although expres-
sion of aquaporin is expected to affect measurements of
swelling-activated ion currents, its identification as a
‘channel regulator’ would have been misleading at best. 
Does the influence of P-glycoprotein on VSOAC have
physiological significance? The availability of mice lacking
P-glycoprotein [6] provides the opportunity to find out,
but such studies of knockout mice may be difficult, given
the small and variable effects observed in cultured cells.
Even with artificially high levels of P-glycoprotein, effects
were small enough to be missed by many observers. Fur-
thermore, at least one cell line selected for a high level of
P-glycoprotein is less sensitive to osmotic challenge than
is the unselected, parental line [27].
Considerable effort has been expended to test the hypoth-
esis that P-glycoprotein encodes VSOAC. That hypothesis
was disproved, and the evidence that P-glycoprotein
expression is correlated with an altered response of
VSOAC, at least in some cell lines, is at present a labora-
tory curiosity with no link to physiology. There is as yet no
evidence that P-glycoprotein is a specific, direct regulator
of VSOAC. More research may yet establish a relationship
of deep and general importance, but such research is
unlikely to be informative until the molecular basis of
VSOAC has been definitively established, and until more
is known about how cell volume changes are signaled to
VSOAC and other cellular elements involved in cell
volume regulation [1]. 
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